Vaccination for Escherichia coli O157:H7 in Feedlot Cattle

Authors

Rodney A. Moxley, University of Nebraska-LincolnFollow
David R. Smith, University of Nebraska-LincolnFollow
Karen Hansen, University of Nebraska-Lincoln
Matt K. Luebbe, University of Nebraska - LincolnFollow
Galen E. Erickson, University of Nebraska-LincolnFollow
Terry J. Klopfenstein, University of Nebraska-LincolnFollow
Dragan Rogan, Bioniche Animal Health, Bioniche Life Sciences, Belleville, Ontario, Canada

Date of this Version

January 2008

Comments

Published in 2008 Nebraska Beef Cattle Report. Copyright © 2007 The Board of Regents of the University of Nebraska.

Abstract

A clinical trial conducted during the summer of 2006 evaluated the effects of two- and three-dose regimens of an Escherichia coli O157 vaccine product on the probability of detecting E. coli O157:H7 in feces and on colonization of the terminal rectum. The three-dose regimen significantly reduced the probability for cattle to shed E. coli O157:H7 in feces by 63% compared to placebo treated cattle. A dose-effect was demonstrated because a two-dose regimen of the vaccine product was intermediate in effect. These results are consistent with previous estimates of vaccine efficacy against fecal shedding and agree with our previous finding that efficacy is related to the number of doses.